Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species

Journal of Neurochemistry

Volumn 85, Issue 6, 2003, Pages 1374-1381

  Oka, Saori ^a   Tsuchie, Akiko ^a   Tokumura, Akira ^a   Muramatsu, Mayumi ^a   Suhara, Yoshitomo ^b   Takayama, Hiroaki ^b   Waku, Keizo ^a   Sugiura, Takayuki ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

2 arachidonoylglycerol; 2 eicosatetraenylglycerol; Brain; Cannabinoid; Ether linked analogue; Noladin ether

Indexed keywords

2 ARACHIDONOYLGLYCEROL; CANNABINOID RECEPTOR; DIHYDROXYACETONE PHOSPHATE; ETHER DERIVATIVE; FATTY ALCOHOL;

ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; FLUOROMETRY; GAS CHROMATOGRAPHY; GUINEA PIG; HAMSTER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAMMAL; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT;

ANIMALS; ARACHIDONIC ACIDS; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRICETINAE; GLYCERIDES; GLYCERYL ETHERS; GUINEA PIGS; MALE; MASS SPECTROMETRY; MICE; RATS; SWINE;

ANIMALIA; CAVIA PORCELLUS; CRICETINAE; MAMMALIA; SUS SCROFA;

EID: 0038810313     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01804.x     Document Type: Article

References (33)

1. Beltramo M. and Piomelli D. (2000) Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuroreport 11, 1231-1235.
2. Bisogno T., Berrendero F., Ambrosino G., Cebeira M., Ramos J. A., Femandez-Ruiz J. J. and Di Marzo V. (1999) Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem. Biophys. Res. Commun. 256, 377-380.
3. Bligh E. J. and Dyer W. J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917.
4. Di Marzo V., Bisogno T., Sugiura T., Melck D. and De Petrocellis L. (1998) The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. Biochem. J. 331, 15-19.
5. Fezza F., Bisogno T., Minassi A., Appendino G., Mechoulam R. and Di Marzo V. (2002) Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues. FEBS Lett. 513, 294-298.
6. Gonsiorek W., Lunn C., Fan X., Narula S., Lundell D. and Hipkin R. W. (2000) Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor antagonism by anandamide. Mol. Pharmacol. 57, 1045-1050.
7. Goparaju S. K., Ueda N., Yamaguchi H. and Yamamoto S. (1998) Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett. 422, 69-73.
8. Goparaju S. K., Ueda N., Taniguchi K. and Yamamoto S. (1999) Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem. Pharmacol. 57, 417-423.
9. Hajra A. K. (1970) Acyl dihydroxyacetone phosphate: precursor of alkyl ethers. Biochem. Biophys. Res. Commun. 39, 1037-1044.
10. Hajra A. K. (1983) Biosynthesis of O-alkylglycerol ether lipids, in Ether Lipids (Mangold H. K. and Paltauf F., eds), pp. 85-106. Academic Press, New York.
11. Hanus S., Abu-Lafi S., Fride E., Breuer A., Vogel Z., Shalev D. E., Kustanovich I. and Mechoulam R. (2001) 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc. Natl Acad. Sci. USA 98, 3662-3665.
12. Hillard C. J. (2000) Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. Prostaglandins Other Lipid Med. 61, 3-18.
13. Horrocks L. A. (1970) Content, composition, and metabolism of mammalian and avian lipids that contain ether groups, in Ether Lipids (Snyder F., ed.), pp. 177-272. Academic Press, New York.
14. Horrocks L. A. and Sharma M. (1982) Plasmalogens and O-alkyl glycerophospholipids, in Phospholipids (Hawthorne J. N. and Ansell G. B., eds), pp. 51-93. Elsevier, Amsterdam.
15. Jarai Z., Wagner J. A., Goparaju S. K., Wang L., Razdan R. K., Sugiura T, Zimmer A. M., Bonner T. I., Zimmer A. and Kunos G. (2000) Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice. Hypertension 35, 679-684.
16. 2+-dependent and -independent mechanisms. FEBS Lett 429, 152-156.
17. Lee M., Yang K. H. and Kaminski N. E. (1995) Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J. Pharmacol. Exp. Ther. 275, 529-536.
18. Mackie K., Devane W. A. and Hille B. (1993) Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol. Pharmacol. 44, 498-503.
19. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N. E., Schatz A. R., Gopher A., Almog S., Martin B. R., Compton D. R., Pertwee R. G., Griffin G., Bayewitch M., Barg J. and Vogel Z. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90.
20. Mechoulam R., Fride E., Ben-Shabat S., Meiri U. and Horowitz M. (1998) Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid. Eur. J. Pharmacol. 362, R1-R3.
21. Savinainen J. R., Jarvinen T., Laine K. and Laitinen J. T. (2001) Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. Br. J. Pharmacol. 134, 664-672.
22. Stella N., Schweitzer P. and Piomelli D. (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388, 773-778.
23. Sugiura T. and Waku K. (1987) Composition of alkyl ether-linked phospholipids in mammalian tissues, in Platelet-Activating Factor and Related Lipid Mediators (Snyder F., ed.), pp. 55-85. Plenum, New York.
24. Sugiura T. and Waku K. (1999) Biosynthesis of platelet-activating factor and structurally related bioactive lipids, in Comprehensive Natural Products Chemistry (Barton D. and Nakanishi K., ed.), Vol. 1, pp. 285-302. Elsevier, Oxford.
25. Sugiura T. and Waku K. (2000) 2-Arachidonoylglycerol and the cannabinoid receptors. Chem. Phys. Lipids 108, 89-106.
26. Sugiura T. and Waku K. (2002) Cannabinoid receptors and their endogenous ligands. J. Biochem. 132, 7-12.
27. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A. and Waku K. (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215, 89-97.
28. 2+ in neuroblastoma x glioma hybrid NG108-15 cells. Biochem. Biophys. Res. Commun. 229, 58-64.
29. 2+ transient in NG108-15 cells. J. Biochem. 122, 890-895.
30. Sugiura T., Kodaka T., Nakane S., Miyashita T., Kondo S., Suhara Y., Takayama H., Waku K., Seki C., Baba N. and Ishima Y. (1999) Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J. Biol. Chem. 274, 2794-2801.
31. Sugiura T., Kondo S., Kishimoto S., Miyashita T., Nakane S., Kodaka T., Suhara Y., Takayama H. and Waku K. (2000) Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J. Biol. Chem. 275, 605-612.
32. Suhara Y., Takayama H., Nakane S., Miyashita T., Waku K. and Sugiura T. (2000) Synthesis and biological activities of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, and its metabolically stable ether-linked analogues. Chem. Pharm. Bull. 48, 903-907.
33. Wykle R. L. and Snyder F. (1976) Microsomal enzymes involved in the metabolism of ether-linked glycerolipids and their precursors in mammals, in The Enzymes of Biological Membranes (Martonosi A., ed.), Vol. 2, pp. 87-117. Plenum, New York.